Pricing power seems to be more important for food stocks than GLP-1 drugs, says Evercore's Palmer

David Palmer, restaurant and packaged food analyst at Evercore ISI, joins 'Squawk on the Street' to discuss whether clients are asking about the impact of GLP-1 drugs, which company stocks have been wrongfully hurt by the new drugs, and more.